var data={"name":"HIV treatment prevention","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Drug resistance","type":"SUBSECTION","items":[{"name":"Interpretation of HIV drug resistance testing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interpretation-of-hiv-drug-resistance-testing"},{"name":"Overview of HIV drug resistance testing assays","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-hiv-drug-resistance-testing-assays"}]},{"name":"Prevention","type":"SUBSECTION","items":[{"name":"Administration of pre-exposure prophylaxis against HIV infection","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=administration-of-pre-exposure-prophylaxis-against-hiv-infection"},{"name":"Effect of herpes simplex virus on HIV infection: Implications for HIV prevention","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=effect-of-herpes-simplex-virus-on-hiv-infection-implications-for-hiv-prevention"},{"name":"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus in HIV-infected patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-genital-herpes-simplex-virus-in-hiv-infected-patients"},{"name":"HIV infection: Risk factors and prevention strategies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hiv-infection-risk-factors-and-prevention-strategies"},{"name":"Management of healthcare personnel exposed to HIV","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-healthcare-personnel-exposed-to-hiv"},{"name":"Management of nonoccupational exposures to HIV and hepatitis B and C in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-nonoccupational-exposures-to-hiv-and-hepatitis-b-and-c-in-adults"},{"name":"Prevention of HIV transmission during breastfeeding in resource-limited settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-hiv-transmission-during-breastfeeding-in-resource-limited-settings"},{"name":"Prevention of mother-to-child HIV transmission in resource-limited settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-mother-to-child-hiv-transmission-in-resource-limited-settings"},{"name":"Treatment of drug-resistant genital herpes simplex virus infection in HIV-infected patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-drug-resistant-genital-herpes-simplex-virus-infection-in-hiv-infected-patients"},{"name":"Treatment of genital herpes simplex virus type 2 in HIV-infected patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-genital-herpes-simplex-virus-type-2-in-hiv-infected-patients"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Abacavir hypersensitivity reaction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=abacavir-hypersensitivity-reaction"},{"name":"Antiretroviral and intrapartum management of pregnant HIV-infected women and their infants in resource-rich settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiretroviral-and-intrapartum-management-of-pregnant-hiv-infected-women-and-their-infants-in-resource-rich-settings"},{"name":"Evaluation of the treatment-experienced patient failing HIV therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-of-the-treatment-experienced-patient-failing-hiv-therapy"},{"name":"Immune reconstitution inflammatory syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-reconstitution-inflammatory-syndrome"},{"name":"Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mitochondrial-toxicity-of-hiv-nucleoside-reverse-transcriptase-inhibitors"},{"name":"Overview of antiretroviral agents used to treat HIV","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-antiretroviral-agents-used-to-treat-hiv"},{"name":"Patient monitoring during HIV antiretroviral therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=patient-monitoring-during-hiv-antiretroviral-therapy"},{"name":"Prenatal evaluation of the HIV-infected woman in resource-rich settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prenatal-evaluation-of-the-hiv-infected-woman-in-resource-rich-settings"},{"name":"Safety and dosing of antiretroviral medications in pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=safety-and-dosing-of-antiretroviral-medications-in-pregnancy"},{"name":"Selecting an antiretroviral regimen for treatment-experienced HIV-infected patients who are failing therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selecting-an-antiretroviral-regimen-for-treatment-experienced-hiv-infected-patients-who-are-failing-therapy"},{"name":"Selecting antiretroviral regimens for the treatment-na√Øve HIV-infected patient","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selecting-antiretroviral-regimens-for-the-treatment-naive-hiv-infected-patient"},{"name":"Switching antiretroviral therapy for HIV-infected adults with suppressed viral loads","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=switching-antiretroviral-therapy-for-hiv-infected-adults-with-suppressed-viral-loads"},{"name":"The impact of antiretroviral therapy on morbidity and mortality of HIV infection in resource-limited settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-impact-of-antiretroviral-therapy-on-morbidity-and-mortality-of-hiv-infection-in-resource-limited-settings"},{"name":"Treatment of HIV-2 infection","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-hiv-2-infection"},{"name":"When to initiate antiretroviral therapy in HIV-infected patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=when-to-initiate-antiretroviral-therapy-in-hiv-infected-patients"}]}]}